Sign in to view content

SCORE2 Month 6 to Month 12 Results: 12 Month Outcomes of Treatment Change among Poor Responders at Month 6

Michael S. Ip, MD

Video
Published 2018

Related

Effect on Treatment Burden Post - Versus Pre-Iluvien Based on Prior DME Treatments
Caesar K. Luo, MD, FASRS
Annual Meeting Talks
2018
Comparative Survival of Patients With Posterior Uveal Melanoma Presenting Class 1A Versus Class 1B Gene Expression Profile
Zelia M. Correa, MD, PhD
Annual Meeting Talks
2018
Intravitreal Aflibercept for Moderately Severe to Severe Non-Proliferative Diabetic Retinopathy (NPDR): The Phase 3 PANORAMA Study
Charles C Wykoff, MD, PhD, FASRS
Annual Meeting Talks
2018

Category: Retinal Vascular Disease

See more